Correlation Between ScanSource and Apollo Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ScanSource and Apollo Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScanSource and Apollo Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScanSource and Apollo Medical Holdings, you can compare the effects of market volatilities on ScanSource and Apollo Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScanSource with a short position of Apollo Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScanSource and Apollo Medical.

Diversification Opportunities for ScanSource and Apollo Medical

ScanSourceApolloDiversified AwayScanSourceApolloDiversified Away100%
0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between ScanSource and Apollo is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding ScanSource and Apollo Medical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollo Medical Holdings and ScanSource is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScanSource are associated (or correlated) with Apollo Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollo Medical Holdings has no effect on the direction of ScanSource i.e., ScanSource and Apollo Medical go up and down completely randomly.

Pair Corralation between ScanSource and Apollo Medical

Assuming the 90 days horizon ScanSource is expected to under-perform the Apollo Medical. But the stock apears to be less risky and, when comparing its historical volatility, ScanSource is 1.44 times less risky than Apollo Medical. The stock trades about -0.31 of its potential returns per unit of risk. The Apollo Medical Holdings is currently generating about -0.21 of returns per unit of risk over similar time horizon. If you would invest  3,500  in Apollo Medical Holdings on January 1, 2025 and sell it today you would lose (720.00) from holding Apollo Medical Holdings or give up 20.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ScanSource  vs.  Apollo Medical Holdings

 Performance 
JavaScript chart by amCharts 3.21.152025FebMar -30-20-10010
JavaScript chart by amCharts 3.21.15SC3 3AM
       Timeline  
ScanSource 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ScanSource has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15FebMarMarApr35404550
Apollo Medical Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Apollo Medical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Apollo Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
JavaScript chart by amCharts 3.21.15FebMarMarApr2830323436

ScanSource and Apollo Medical Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.32-3.24-2.15-1.070.01460.881.762.633.51 0.0450.0500.0550.0600.065
JavaScript chart by amCharts 3.21.15SC3 3AM
       Returns  

Pair Trading with ScanSource and Apollo Medical

The main advantage of trading using opposite ScanSource and Apollo Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScanSource position performs unexpectedly, Apollo Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollo Medical will offset losses from the drop in Apollo Medical's long position.
The idea behind ScanSource and Apollo Medical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamental Analysis
View fundamental data based on most recent published financial statements